t2513

T-2513 is a potent and specific inhibitor of topoisomerase I. It acts by forming covalent bonds with the topoisomerase I-DNA complex, thereby enhancing its stability. This interaction disrupts the normal process of DNA replication and RNA synthesis, ultimately resulting in cellular apoptosis.

VX702 是一种高度特异性的 p38α MAPK 抑制剂，对 p38α 的选择性比 p38β 高 14 倍。它是一种小分子研究口服抗细胞因子疗法，用于治疗炎症性疾病，如类风湿性关节炎。

CVT-2513 is a metabolite of Renolazine, which has anti-myocardial ischemia effect.

T-2513 hydrochloride 是拓扑异构酶 I (topoisomerase I) 的选择性抑制剂。T-2513 hydrochloride 能够共价结合拓扑异构酶 I-DNA 复合物，保持其稳定性，并能够抑制 DNA 复制和 RNA 合成，导致细胞死亡。